Two of the hospital's physicians explain how the decision support technology aggregates patient signals to indicate health ...
A policy meant to protect patients instead exposes how prejudice can hide behind the language of public health ...
22h
Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD
Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease (COPD) showed that tozorakimab reduced the annualized rate of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results